Research Article

Synthesis of Novel Diclofenac Hydrazones: Molecular Docking, Anti-Inflammatory, Analgesic, and Ulcerogenic Activity

Table 1

Effect of compounds on carrageenan-induced paw edema in albino rats.

Treatments (n = 6)Dose mg/kgBefore treatmentMean increase in paw volume
1 hour2 hours3 hours
Mean ± SENet% changeMean ± SENet% changeMean ± SENet% Change

Carrageenan1.10 ± 0.011.70 ± 0.010.60 ± 0.0061.70 ± 0.010.60 ± 0.011.66 ± 0.010.56 ± 0.01
Diclofenac101.11 ± 0.011.45 ± 0.020.33 ± 0.0244.351.33 ± 0.010.21 ± 0.00564.561.29 ± 0.0090.17 ± 0.0169.02
114.461.10 ± 0.011.69 ± 0.0080.58 ± 0.012.751.64 ± 0.010.54 ± 0.0210.711.56 ± 0.020.46 ± 0.0218.28
215.471.12 ± 0.0081.54 ± 0.010.42 ± 0.00829.751.41 ± 0.040.29 ± 0.0451.091.36 ± 0.020.24 ± 0.0256.93
315.471.11 ± 0.011.49 ± 0.0090.38 ± 0.00636.911.39 ± 0.0090.28 ± 0.0153.841.33 ± 0.010.21 ± 0.0161.65
4151.11 ± 0.011.55 ± 0.010.44 ± 0.0126.721.57 ± 0.010.46 ± 0.0723.621.57 ± 0.010.46 ± 0.0117.99
515.471.11 ± 0.011.68 ± 0.010.56 ± 0.0076.881.65 ± 0.010.53 ± 0.00711.531.55 ± 0.010.44 ± 0.00921.82
614.61.09 ± 0.011.68 ± 0.010.58 ± 0.013.581.60 ± 0.010.50 ± 0.0116.751.51 ± 0.010.42±±0.0125.36
715.471.11 ± 0.011.54 ± 0.010.43 ± 0.0128.921.46 ± 0.020.35 ± 0.0142.301.38 ± 0.010.26 ± 0.0153.39
8161.11 ± 0.011.44 ± 0.010.33 ± 0.00445.171.35 ± 0.010.24 ± 0.0160.161.31 ± 0.010.19 ± 0.0165.48
916.51.10 ± 0.011.66 ± 0.020.56 ± 0.017.431.62 ± 0.020.52 ± 0.0114.011.59 ± 0.010.49 ± 0.00812.68
1016.51.12 ± 0.011.70 ± 0.0080.58 ± 0.0083.851.68 ± 0.010.56±±0.017.691.62 ± 0.010.50 ± 0.0111.20
11161.13 ± 0.011.54 ± 0.010.40 ± 0.0133.051.46 ± 0.010.32 ± 0.0146.421.38 ± 0.0090.24 ± 0.0156.34
1214.51.11 ± 0.011.70 ± 0.010.58 ± 0.0073.031.65 ± 0.010.53 ± 0.0112.081.56 ± 0.010.44 ± 0.0121.53
1314.51.11 ± 0.011.58 ± 0.020.46 ± 0.0123.411.42 ± 0.00.31 ± 0.0148.901.36 ± 0.010.24 ± 0.0156.63
14151.09 ± 0.011.59 ± 0.0080.50 ± 0.00817.071.61 ± 0.010.51 ± 0.00715.101.51 ± 0.010.41 ± 0.0225.95

All values represent mean ± SEM. ; ; , followed by Student’s t-test.